The authors report the case of a 70-year-old man with metastatic colon cancer and no known history of coronary disease or major risk factors who developed coronary vasospasm after the initiation of capecitabine (Xeloda). Although coronary vasospasm has been associated with another older fluoropyrimidine compound, 5-fluorouracil, this is the first reported occurrence with this relatively newer cancer drug.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/000331970405500114 | DOI Listing |
Publication Analysis
Top Keywords
coronary vasospasm
8
capecitabine-induced coronary
4
coronary vasospasm--a
4
vasospasm--a case
4
case report
4
report authors
4
authors report
4
report case
4
case 70-year-old
4
70-year-old man
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!